Insight

Latest California Healthline Stories

FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns

The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors. The problems they found at the company’s main U.S. drug-testing laboratory in Foster City, Calif., were so bad, they recommended withholding approval.

Cigarettes Vs. Vaping: That’s The ‘Wrong Comparison,’ Says Inhalation Researcher

Ilona Jaspers, an inhalation toxicologist at the University of North Carolina at Chapel Hill, believes the common notion of comparing e-cigarettes with traditional, combustible cigarettes is the wrong analogy because the vaping products expose consumers to chemicals in a fundamentally different way.

KHN’s ‘What The Health?’: Spooky Stuff

If it’s Halloween, that means open enrollment for plans on the Affordable Care Act exchanges is right around the corner. Prices are down this year, but the future of the health law remains in doubt due to a lawsuit seeking to have the entire measure thrown out. This week, Stephanie Armour of The Wall Street Journal, Mary Agnes Carey of Kaiser Health News and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, the panelists read the top entries in KHN’s Halloween Health Haiku Contest.